drugset / Trial / NCT02721576
A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC
NaSingle-groupOpen-labelTreatment
Summary
This is a perspective, multicenter,single arm, open study to evaluate the efficacy and safety of treatment with CMNa combined with concurrent chemoradiotherapy in patients with locally recurrent squamous cell esophageal carcinoma . Analyses of primary objective (ORR) will be done as defined in the protocol.
Timeline
- Start
- 2016-07-05
- Primary completion
- 2018-06-30
- Completion
- 2018-07-30
Outcome
Outcome not reported
Stopped (Enrollment): “The number of enrolled cases is too small.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Glycididazole | Small molecule | 800 mg/m2 | Intravenous |